Babban dalilin da likitanku yake so ya rage ƙananan cholesterol shine rage yawan hadarin zuciya da rashin mutuwa daga cututtukan cututtuka (CAD).
Kuma duk da cewa an riga an yarda da yawancin magunguna don rage LDL cholesterol (LDL shine "mummunan" nau'in cholesterol), kawai kwayoyi da aka nuna akai-akai don rage hadarin ciwon zuciya da kuma rashin mutuwa a cikin mutanen da ke da cututtukan zuciya haɗarin haɗari ne statins .
A gaskiya ma, manyan bincike sun nuna cewa wasu daga magungunan ba-stin cholesterol na iya kara tsanantawa.
A halin yanzu, anyi zaton cewa kwayoyin sun fi sauran kwayoyi karfi wajen inganta sakamakon saboda suna da tasiri masu amfani mai ban sha'awa da haɓakar cholesterol-downering capabilities. Wadannan sakamako na "karin" zasu iya taimakawa wajen hana rushewa na asherosclerotic a cikin suturar jijiyoyin jini kuma zai iya taimakawa wajen hana ciwo mai jijiyar zuciya .
Ƙananan Cholesterol-Saukewa na Ƙarin Statut
Ƙarin "ƙananan" ba-cholesterol-lowering effects of statins sun hada da:
- Wani sakamako mai kumburi.
- Wani sakamako na anti-clotting.
- Matsayi mai dorewa ta kai tsaye.
- Ragewa a cikin matakan gina jiki C-reactive (CRP)
- An cigaba da aikin aikin jijiyoyin.
- Ragewa a cikin arrhythmias na cardiac mai hatsari.
- Wasu rikici (shrinking) na siffofin atherosclerotic kansu.
Wadannan "karin" illa na statins na iya zama mahimmanci (ko ma mahimmanci) fiye da rage yawan cholesterol don inganta sakamakon.
Alal misali, waɗannan cututtukan da ba cholesterol na iya zama dalili cewa bayar da statins a yayin da ake fama da mummunan zuciya ya ba da amfani ga asibiti a nan gaba - wannan ba wani sakamako ba ne wanda za ku yi tsammanin idan abu guda kawai ya kasance shine ya rage cholesterol. Wadannan cututtukan ƙananan cholesterol zasu iya bayyana dalilin da yasa statins zai iya inganta sakamakon a wasu marasa lafiya marasa lafiya wanda ƙananan cholesterol ba su ɗauke da su ba.
Lallai, abubuwan da suka dace na statins sun sa wasu masana su tambayi dukan " maganin cholesterol " (ma'anar cewa rage yawan cholesterol zai rage hadarin). Wadannan "litattafan" sunyi imani ba wai rage yawan LDL cholesterol da ke sa statins ya inganta wajen inganta sakamakon ba, amma sauran cututtukan kwayoyi. Don haka (sun ci gaba da bayar da shawara) watakila ragewa cholesterol kanta ba mahimmanci kamar yadda muke tunani ba.
Layin Ƙasa
Ko ta yaya, idan likitanku ya bada shawarar likita a matsayin likita mafi kyawun maganin likitan ku na LDL cholesterol, tana nuna kwarewarsa ne kawai game da hujjojin shaida da ke nuna cewa statins suna da amfani sosai.
Za ka iya karanta game da sauran ƙwayoyin cholesterol-downering far . Kuma a nan labarin ne game da yadda za a yanke shawara ko kana bukatar a bi da ku don cholesterol.
> Sources:
> Liu PY, Liu YW, Lin LJ, et al. Shaida Ga Pleiotropy na Patin A cikin Mutum: Daban Daban Daban Dabbobi da kuma Ezetimibe A Rubuce-Rubuce-Rubuce-Rubuce-Rubuce-Rubucewa da ke ɗauke da Kwayar Kwayoyin Ciniki, Ayyukan Endothelial, da Kumburi. Yanayi na 2009; 119: 131.
> Nissen, SE. Matsanancin Bayanai a cikin Raunin Harshen Coronary Syndromes. Ba kawai lakabi ne kawai ba. JAMA 2004; 292: 1365.
> Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC / Dokokin Sharuɗɗa a kan Ciwon Cholesterol na jini don Rage Ciwon Kwayoyin Tsarin Lafiya na Atherosclerotic A Manya: Rahoton Cibiyar Harkokin Kasuwancin Amirka da Cibiyar Harkokin Kasuwancin Amirka ta Harkokin Kasuwanci. Hanya 2014; 129: S1.